Sleep-Disordered Breathing and Metabolic Effects: Evidence from Animal Models

Sleep Medicine Clinics

Volumn 2, Issue 2, 2007, Pages 263-277

  Jun, Jonathan ^a   Polotsky, Vsevolod Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; AIRWAY OBSTRUCTION; DISEASE MODEL; GLUCOSE INTOLERANCE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID PEROXIDATION; METABOLIC DISORDER; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SLOW WAVE SLEEP; TRANSCRIPTION REGULATION;

EID: 64749107053     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.03.009     Document Type: Review

References (201)

1. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 5 (2002) 677-682
2. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. [see comments]. J Clin Endocrinol Metab 85 3 (2000) 1151-1158
3. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 17 (1993) 1230-1235
4. Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 25 (2002) 3143-3421
5. Wilcox I., McNamara S.G., Collins F.L., et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 Suppl 3 (1998) S25-S28
6. Schwartz A.R., Gold A.R., Schubert N., et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 144 3 Pt 1 (1991) 494-498
7. Smith P.L., Gold A.R., Meyers D.A., et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 103 6 Pt 1 (1985) 850-855
8. Burwell C.S., Robin E.D., Whaley R.D., et al. Extreme obesity associated with alveolar hypoventilation-A Pickwickian syndrome. Am J Med 21 5 (1956) 811-818
9. Phipps P.R., Starritt E., Caterson I., et al. Association of serum leptin with hypoventilation in human obesity. Thorax 57 1 (2002) 75-76
10. Grunstein R.R., and Sullivan C.E. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med 85 6 (1988) 775-779
11. Grunstein R.R., Ho K.Y., and Sullivan C.E. Sleep apnea in acromegaly. Ann Intern Med 115 7 (1991) 527-532
12. Punjabi N.M., and Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99 5 (2005) 1998-2007
13. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26 3 (2003) 702-709
14. Weiss V., Sonka K., Pretl M., et al. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 23 8 (2000) 515-519
15. Bottini P., and Tantucci C. Sleep apnea syndrome in endocrine diseases. Respiration 70 3 (2003) 320-327
16. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. [see comments]. JAMA 283 14 (2000) 1829-1836
17. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 19 (2000) 1378-1384
18. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 5 (2002) 670-676
19. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 6 (2004) 521-530
20. Reichmuth K.J., Austin D., Skatrud J.B., et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172 12 (2005) 1590-1595
21. Suzuki T., Nakano H., Maekawa J., et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 27 1 (2004) 129-133
22. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 5 (2005) 613-618
23. Minoguchi K., Yokoe T., Tazaki T., et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172 5 (2005) 625-630
24. Leineweber C., Kecklund G., Janszky I., et al. Snoring and progression of coronary artery disease: the Stockholm Female Coronary Angiography Study. Sleep 27 7 (2004) 1344-1349
25. Hendricks J.C., Kline L.R., Kovalski R.J., et al. The English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol 63 4 (1987) 1344-1350
26. Hendricks J.C., Kovalski R.J., and Kline L.R. Phasic respiratory muscle patterns and sleep-disordered breathing during rapid eye movement sleep in the English bulldog. Am Rev Respir Dis 144 5 (1991) 1112-1120
27. Schotland H.M., Insko E.K., Panckeri K.A., et al. Quantitative magnetic resonance imaging of upper airways musculature in an animal model of sleep apnea. J Appl Physiol 81 3 (1996) 1339-1346
28. Petrof B.J., Pack A.I., Kelly A.M., et al. Pharyngeal myopathy of loaded upper airway in dogs with sleep apnea. J Appl Physiol 76 4 (1994) 1746-1752
29. Veasey S.C., Fenik P., Panckeri K., et al. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 160 5 Pt 1 (1999) 1659-1667
30. Veasey S.C., Chachkes J., Fenik P., et al. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 24 2 (2001) 155-160
31. Lonergan R.P., Ware J.C., Atkinson R.L., et al. Sleep apnea in obese miniature pigs. J Appl Physiol 84 2 (1998) 531-536
32. Philip P., Gross C.E., Taillard J., et al. An animal model of a spontaneously reversible obstructive sleep apnea syndrome in the monkey. Neurobiol Dis 20 2 (2005) 428-431
33. Sahin M., Durand D.M., and Haxhiu M.A. Closed-loop stimulation of hypoglossal nerve in a dog model of upper airway obstruction. IEEE Trans Biomed Eng 47 7 (2000) 919-925
34. Nour S.G., Lewin J.S., Gutman M., et al. Percutaneous MR imaging-guided radiofrequency interstitial thermal ablation of tongue base in porcine models: implications for obstructive sleep apnea syndrome. Radiology 230 2 (2004) 359-368
35. Chen L., Shi Q., and Scharf S.M. Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88 3 (2000) 1051-1060
36. Chen L., and Scharf S.M. Effects of aortic nerve on hemodynamic response to obstructive apnea in sedated pigs. J Appl Physiol 89 4 (2000) 1455-1461
37. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. [see comments]. J Clin Invest 99 1 (1997) 106-109
38. Schneider H., Schaub C.D., Chen C.A., et al. Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol 88 3 (2000) 1093-1102
39. Farre R., Rotger M., Montserrat J.M., et al. Collapsible upper airway segment to study the obstructive sleep apnea/hypopnea syndrome in rats. Respir Physiol Neurobiol 136 2-3 (2003) 199-209
40. Nacher M., Serrano-Mollar A., Farre R., et al. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155 1 (2007) 93-96
41. Kimoff R.J., Makino H., Horner R.L., et al. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 76 4 (1994) 1810-1817
42. Parker J.D., Brooks D., Kozar L.F., et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160 6 (1999) 1888-1896
43. Horner R.L., Brooks D., Kozar L.F., et al. Sleep architecture in a canine model of obstructive sleep apnea. Sleep 21 8 (1998) 847-858
44. O'Donnell C.P., Ayuse T., King E.D., et al. Airway obstruction during sleep increases blood pressure without arousal. J Appl Physiol 80 3 (1996) 773-781
45. Tagaito Y., Polotsky V.Y., Campen M.J., et al. A model of sleep-disordered breathing in the C57BL/6 J mouse. J Appl Physiol 91 6 (2001) 2758-2766
46. Strohl K.P. Con: sleep apnea is not an anatomic disorder. Am J Respir Crit Care Med 168 3 (2003) 271-272
47. Hamrahi H., Stephenson R., Mahamed S., et al. Selected contribution: regulation of sleep-wake states in response to intermittent hypoxic stimuli applied only in sleep. J Appl Physiol 90 6 (2001) 2490-2501
48. Polotsky V.Y., Li J., Punjabi N.M., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552 Pt 1 (2003) 253-264
49. Fletcher E.C., Lesske J., Qian W., et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. [see comments]. Hypertension 19 6 Pt 1 (1992) 555-561
50. Fletcher E.C., Lesske J., Culman J., et al. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20 5 (1992) 612-619
51. Fletcher E.C., Bao G., and Miller III C.C. Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J Appl Physiol 78 4 (1995) 1516-1521
52. Fletcher E.C., and Bao G. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19 10 Suppl (1996) S210-S212
53. Fletcher E.C., and Bao G. Effect of episodic eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats. J Appl Physiol 81 5 (1996) 2088-2094
54. Gozal D., Daniel J.M., and Dohanich G.P. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 21 7 (2001) 2442-2450
55. Veasey S.C., Davis C.W., Fenik P., et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27 2 (2004) 194-201
56. Polotsky V.Y., Rubin A.E., Balbir A., et al. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6 J mouse. Sleep Med 7 1 (2006) 7-16
57. Li J., Grigoryev D.N., Ye S.Q., et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99 5 (2005) 1643-1648
58. Li J., Thorne L.N., Punjabi N.M., et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97 7 (2005) 698-706
59. Li J., Savransky V., Nanayakkara A., et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 175 8 (2007) 851-857
60. Li J., Bosch-Marce M., Nanayakkara A., et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25 3 (2006) 450-457
61. Waters K.A., and Tinworth K.D. Habituation of arousal responses after intermittent hypercapnic hypoxia in piglets. Am J Respir Crit Care Med 171 11 (2005) 1305-1311
62. Arzt M., Young T., Finn L., et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166 16 (2006) 1716-1722
63. Brooks D., Horner R.L., Kimoff R.J., et al. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 155 5 (1997) 1609-1617
64. Braun B., Rock P.B., Zamudio S., et al. Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91 2 (2001) 623-631
65. Larsen J.J., Hansen J.M., Olsen N.V., et al. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504 Pt 1 (1997) 241-249
66. Oltmanns K.M., Gehring H., Rudolf S., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169 11 (2004) 1231-1237
67. Calderon R., Llerena L.A., Munive L., et al. Intravenous glucose tolerance test in pregnancy in women living in chronic hypoxia. Diabetes 15 2 (1966) 130-132
68. Davidson M.B., and Aoki V.S. Fasting glucose homeostasis in rats after chronic exposure to hypoxia. Am J Physiol 219 2 (1970) 378-383
69. Pomplun D., Mohlig M., Spranger J., et al. Elevation of blood glucose following anaesthetic treatment in C57BL/6 mice. Horm Metab Res 36 1 (2004) 67-69
70. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 3 (1979) E214-E223
71. Iiyori N., Li J., Sanders M.H., et al. Intermittent hypoxia causes insulin resistance through non-hepatic mechanisms. Proc Am Thorac Soc 2 (2005) A232
72. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
73. Fenik V., Swan J., Volgin D.V., et al. Chronic intermittent hypoxia causes diabetes-like changes in normal rats. Proc Am Thorac Soc 2 (2006) A232
74. Savransky V., Nanayakkara A., Vivero A., et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45 4 (2007) 1007-1013
75. Yuan G., Nanduri J., Bhasker C.R., et al. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280 6 (2005) 4321-4328
76. Cai Z., Manalo D.J., Wei G., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 1 (2003) 79-85
77. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 17 (2005) 2660-2667
78. Semenza G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8 5 (1998) 588-594
79. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13 2 (2001) 167-171
80. Goyal P., Weissmann N., Grimminger F., et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic Biol Med 36 10 (2004) 1279-1288
81. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 1 (2004) 123-128
82. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 566-570
83. Row B.W., Kheirandish L., Neville J.J., et al. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 52 3 (2002) 449-453
84. Zhan G., Serrano F., Fenik P., et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172 7 (2005) 921-929
85. Chen L., Einbinder E., Zhang Q., et al. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172 7 (2005) 915-920
86. Wang G.L., Jiang B.H., Rue E.A., et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92 12 (1995) 5510-5514
87. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270 3 (1995) 1230-1237
88. Semenza G.L., Roth P.H., Fang H.M., et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269 38 (1994) 23757-23763
89. Iyer N.V., Kotch L.E., Agani F., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 2 (1998) 149-162
90. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 9 (1996) 4604-4613
91. Semenza G.L. Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis. Hematol Oncol Clin North Am 8 5 (1994) 863-884
92. Feldser D., Agani F., Iyer N.V., et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59 16 (1999) 3915-3918
93. Clemmons D.R. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 6 6 (2006) 620-625
94. Ambrosini G., Nath A.K., Sierra-Honigmann M.R., et al. Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 277 37 (2002) 34601-34609
95. Barzilai N., Wang J., Massilon D., et al. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 100 12 (1997) 3105-3110
96. Sivitz W.I., Walsh S.A., Morgan D.A., et al. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138 8 (1997) 3395-3401
97. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40 6 (2001) 439-452
98. Horton J.D., Bashmakov Y., Shimomura I., et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A 95 11 (1998) 5987-5992
99. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 9 (2002) 1125-1131
100. Shimomura I., Hammer R.E., Richardson J.A., et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12 20 (1998) 3182-3194
101. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274 42 (1999) 30028-30032
102. Yamashita K., Discher D.J., Hu J., et al. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 276 16 (2001) 12645-12653
103. Wilkes J.J., Hevener A., and Olefsky J. Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 52 8 (2003) 1904-1909
104. Ottosson-Seeberger A., Lundberg J.M., Alvestrand A., et al. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 161 2 (1997) 211-220
105. Greenberg H., Ye X., Wilson D., et al. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343 2 (2006) 591-596
106. Bubici C., Papa S., Pham C.G., et al. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 21 1 (2006) 69-80
107. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 210 (2006) 171-186
108. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 5 (1986) 705-716
109. de Winther M.P., Kanters E., Kraal G., et al. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25 5 (2005) 904-914
110. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 18 (2004) 2195-2224
111. Yamamoto Y., and Gaynor R.B. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29 2 (2004) 72-79
112. Kim J.K., Kim Y.J., Fillmore J.J., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108 3 (2001) 437-446
113. Yin M.J., Yamamoto Y., and Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396 6706 (1998) 77-80
114. Yu Y.H., and Ginsberg H.N. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96 10 (2005) 1042-1052
115. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 3 (1998) 847-850
116. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 5091 (1993) 87-91
117. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174 7 (2006) 824-830
118. Branen L., Hovgaard L., Nitulescu M., et al. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24 11 (2004) 2137-2142
119. Huber S.A., Sakkinen P., Conze D., et al. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19 10 (1999) 2364-2367
120. Kirii H., Niwa T., Yamada Y., et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23 4 (2003) 656-660
121. Mallat Z., Besnard S., Duriez M., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 85 8 (1999) e17-e24
122. Egashira K., Zhao Q., Kataoka C., et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90 11 (2002) 1167-1172
123. Cybulsky M.I., Iiyama K., Li H., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107 10 (2001) 1255-1262
124. Collins R.G., Velji R., Guevara N.V., et al. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191 1 (2000) 189-194
125. Johnson R.C., Chapman S.M., Dong Z.M., et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 99 5 (1997) 1037-1043
126. Schreyer S.A., Peschon J.J., and LeBoeuf R.C. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271 42 (1996) 26174-26178
127. Chin K., Nakamura T., Shimizu K., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109 7 (2000) 562-567
128. Robinson G.V., Pepperell J.C., Segal H.C., et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59 9 (2004) 777-782
129. Ohga E., Nagase T., Tomita T., et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87 1 (1999) 10-14
130. Ohga E., Tomita T., Wada H., et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94 1 (2003) 179-184
131. Carlson J.T., Hedner J., Elam M., et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 6 (1993) 1763-1768
132. Hedner J., Darpo B., Ejnell H., et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8 2 (1995) 222-229
133. Narkiewicz K., van de Borne P.J., Cooley R.L., et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 8 (1998) 772-776
134. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 23 (1999) 2332-2335
135. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
136. Dimsdale J.E., Coy T., Ziegler M.G., et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18 5 (1995) 377-381
137. Hedner J., Ejnell H., Sellgren J., et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 6 4 (1988) S529-S531
138. Leuenberger U., Jacob E., Sweer L., et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79 2 (1995) 581-588
139. Smith M.L., Niedermaier O.N., Hardy S.M., et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 56 3 (1996) 184-190
140. Somers V.K., Mark A.L., Zavala D.C., et al. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67 5 (1989) 2101-2106
141. Bao G., Metreveli N., Li R., et al. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83 1 (1997) 95-101
142. Kumar G.K., Rai V., Sharma S.D., et al. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575 Pt 1 (2006) 229-239
143. Moller D.S., Lind P., Strunge B., et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16 4 (2003) 274-280
144. Fletcher E.C., Bao G., and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34 2 (1999) 309-314
145. Iiyori N., Li J., Sanders M.H., et al. Insulin resistance during intermittent hypoxia is independent of activation of the autonomic nervous system. Proc Am Thorac Soc 3 (2006) A194
146. Krozowski Z. The 11beta-hydroxysteroid dehydrogenases: functions and physiological effects. Mol Cell Endocrinol 151 1-2 (1999) 121-127
147. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes?. Med Sci Monit 9 2 (2003) RA35-RA39
148. Parlapiano C., Borgia M.C., Minni A., et al. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31 4 (2005) 371-374
149. Wang T.Y., Chen X.Q., Du J.Z., et al. Corticotropin-releasing factor receptor type 1 and 2 mRNA expression in the rat anterior pituitary is modulated by intermittent hypoxia, cold and restraint. Neuroscience 128 1 (2004) 111-119
150. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 3 (1995) 172-179
151. Saini J., Krieger J., Brandenberger G., et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 7 (1993) 375-381
152. Chen X.Q., Xu N.Y., Du J.Z., et al. Corticotropin-releasing factor receptor subtype 1 and somatostatin modulating hypoxia-caused downregulated mRNA of pituitary growth hormone and upregulated mRNA of hepatic insulin-like growth factor-I of rats. Mol Cell Endocrinol 242 1-2 (2005) 50-58
153. Xu N.Y., Chen X.Q., Du J.Z., et al. Intermittent hypoxia causes a suppressed pituitary growth hormone through somatostatin. Neuro Endocrinol Lett 25 5 (2004) 361-367
154. Breslow M.J., Min-Lee K., Brown D.R., et al. Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276 3 Pt 1 (1999) E443-E449
155. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. [see comments]. N Engl J Med 334 5 (1996) 292-295
156. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 6704 (1998) 763-770
157. Maffei M., Halaas J., Ravussin E., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 (1995) 1155-1161
158. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479]. [see comments]. Nature 372 6505 (1994) 425-432
159. Chin K., Shimizu K., Nakamura T., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 7 (1999) 706-712
160. Ip M.S., Lam K.S., Ho C., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. [see comments]. Chest 118 3 (2000) 580-586
161. Vgontzas A., Bixler E., Papanicolaou D., et al. Plasma concentrations of tumor necrosis factor alpha (TNF), interleukin-6 (IL-6) and leptin are elevated in sleep apnea independent of obesity. Sleep 22 (1999) S331 [abstract]
162. Kulkarni R.N., Wang Z.L., Wang R.M., et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100 11 (1997) 2729-2736
163. Seufert J., Kieffer T.J., and Habener J.F. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A 96 2 (1999) 674-679
164. Sivitz W.I., Walsh S., Morgan D., et al. Plasma leptin in diabetic and insulin-treated diabetic and normal rats. Metabolism 47 5 (1998) 584-591
165. Lin C.Y., Higginbotham D.A., Judd R.L., et al. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 282 5 (2002) E1084-E1091
166. Farooqi I.S., Keogh J.M., Kamath S., et al. Partial leptin deficiency and human adiposity. Nature 414 6859 (2001) 34-35
167. Montague C.T., Farooqi I.S., Whitehead J.P., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 6636 (1997) 903-908
168. Ravussin E., Pratley R.E., Maffei M., et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 3 2 (1997) 238-240
169. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278 11 (2003) 9073-9085
170. Steppan C., Bailey S., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
171. Masserini B., Morpurgo P.S., Donadio F., et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29 8 (2006) 700-705
172. Wolk R., Svatikova A., Nelson C.A., et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13 1 (2005) 186-190
173. Harsch I.A., Koebnick C., Wallaschofski H., et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation?. Med Sci Monit 10 9 (2004) CR510-CR515
174. Chen B., Lam K.S., Wang Y., et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341 2 (2006) 549-556
175. Raff H., and Bruder E.D. Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia. Endocrine 29 2 (2006) 341-344
176. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 6762 (1999) 656-660
177. Shintani M., Ogawa Y., Ebihara K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 2 (2001) 227-232
178. Harsch I.A., Konturek P.C., Koebnick C., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22 2 (2003) 251-257
179. Ulukavak C.T., Kokturk O., Bukan N., et al. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 72 4 (2005) 395-401
180. Raff H. Total and active ghrelin in developing rats during hypoxia. Endocrine 21 2 (2003) 159-161
181. Bruder E.D., Jacobson L., and Raff H. Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J Endocrinol 185 3 (2005) 477-484
182. Massumi R.A., and Winnacker J.L. Severe depression of the respiratory center in myxedema. Am J Med 36 (1964) 876-882
183. Jha A., Sharma S.K., Tandon N., et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 7 1 (2006) 55-61
184. Kapur V.K., Koepsell T.D., deMaine J., et al. Association of hypothyroidism and obstructive sleep apnea. Am J Respir Crit Care Med 158 5 Pt 1 (1998) 1379-1383
185. Resta O., Carratu P., Carpagnano G.E., et al. Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS). J Endocrinol Invest 28 10 (2005) 893-898
186. Sawhney R.C., and Malhotra A.S. Thyroid function during intermittent exposure to hypobaric hypoxia. Int J Biometeorol 34 3 (1990) 161-163
187. Newman A.B., Nieto F.J., Guidry U., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154 1 (2001) 50-59
188. Tan K.C., Chow W.S., Lam J.C., et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184 2 (2006) 377-382
189. Tanne F., Gagnadoux F., Chazouilleres O., et al. Chronic liver injury during obstructive sleep apnea. Hepatology 41 6 (2005) 1290-1296
190. Tatsumi K., and Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 33 2 (2005) 100-104
191. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 2 (2004) 147-152
192. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40 9 (1999) 1549-1558
193. Ntambi J.M., and Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 43 2 (2004) 91-104
194. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 9188 (1999) 1435-1439
195. Spiegel K., Knutson K., Leproult R., et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99 5 (2005) 2008-2019
196. Spiegel K., Tasali E., Penev P., et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141 11 (2004) 846-850
197. Vorona R.D., Winn M.P., Babineau T.W., et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165 1 (2005) 25-30
198. Gangwisch J.E., Malaspina D., Boden-Albala B., et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28 10 (2005) 1289-1296
199. Stamatakis KA, Punjabi NM. Physiological manifestations of experimental sleep fragmentation in normal subjects. Presented at the APSS meeting. Minneapolis, June 9-14, 2007.
200. Stamatakis KA, Punjabi NM. Effects of experimental sleep fragmentation on glucose metabolism in normal subjects. APSS meeting, 2007.
201. Peng Y.J., Yuan G., Ramakrishnan D., et al. Heterozygous HIF-1{alpha} deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577 Pt 2 (2006) 705-716